We wrote about the legislative efforts and campaigns targeting nonhuman animal research in the US earlier this year. There, we took a broad look at some current campaigns, discussed mechanisms for various types of legislative efforts, and made suggestions for action. Today we look at the current status of legislation we wrote about in July, … Continue reading Nov 2019 Update: What’s happening with campaigns and legislation aimed at US animal research and testing
Welcome to this week’s Research Roundup. These Friday posts aim to inform our readers about the many stories that relate to animal research each week. Do you have an animal research story we should include in next week’s Research Roundup? You can send it to us via our Facebook page or through the contact form … Continue reading Research Roundup: Considering the bleak future of animal research without primates, heroin vaccine brought one step closer to availability and more!
On Friday, January 26, the US Food and Drug Administration (FDA)—the agency charged with protecting public health via oversight of food, drugs, and medical devices—issued a statement about its decision to terminate a nicotine research project at the National Center for Toxicology Research (NCTR). The research had been the focus of campaign by an anti-animal … Continue reading FDA announcement regarding termination of primate study leaves many questions unanswered
The FDA Commissioner, Scott Gottlieb, made a statement last week that claimed animal welfare concerns had led to his agency’s decision to end a primate research project aimed at better understanding nicotine addiction in adolescents. However, details revealed in the project documents that were also released by the agency last week raise doubts about the … Continue reading The Curious Case of Catheter Removals at the FDA
The US Food and Drug Administration (FDA) announced yesterday that it terminated a study investigating the effects of nicotine in monkeys. This announcement, which was accompanied by the release of many records and documents related to the animals’ care, is troubling for many reasons. Among them, it again raises questions about oversight and decision-making. Nicotine … Continue reading Response to FDA statement on termination of a primate nicotine research study